Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Phase 1 Unknown
42 enrolled
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas
Phase 1 Unknown
50 enrolled
NYMC195
Phase 1 Unknown
30 enrolled
A Dose Finding Study to Treat Bone Tumor(s)
Phase 1 Unknown
17 enrolled
ANCHOR2
Phase 1 Unknown
36 enrolled
NY-ESO-1-specific T Cell Receptor (TCR) T Cell in Sarcoma
Phase 1 Unknown
20 enrolled
TAEST16001 in the Treatment of Soft Tissue Sarcoma
Phase 1 Unknown
12 enrolled
OLATRASTS
Phase 1 Unknown
28 enrolled
GEN602
Phase 1 Unknown
127 enrolled
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
Phase 1 Unknown
30 enrolled
Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors
Phase 1 Unknown
30 enrolled
Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children
Phase 1 Unknown
36 enrolled
Phase â… Clinical Study Protocol of GB223 Monoclonal Antibody Injection
Phase 1 Unknown
44 enrolled
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour
Phase 1 Unknown
10 enrolled
CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin
Phase 1 Unknown
46 enrolled
Investigator Initiated Phase 1 Study of TBI-1301
Phase 1 Unknown
9 enrolled
A Study Evaluating MM-310 in Patients With Solid Tumors
Phase 1 Unknown
34 enrolled
T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies
Phase 1 Unknown
36 enrolled
Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas
Phase 1 Unknown
28 enrolled
TH-CR-410
Phase 1 Unknown
58 enrolled
IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma
Phase 1 Unknown
30 enrolled
Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma
Phase 1 Unknown
10 enrolled
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
Phase 1 Unknown
20 enrolled
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors
Phase 1 Unknown
24 enrolled
Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Phase 1 Unknown
Phosphorus 32 in Treating Patients With Glioblastoma Multiforme
Phase 1 Unknown
12 enrolled
Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma
Phase 1 Unknown
36 enrolled
Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors
Phase 1 Unknown
15 enrolled
Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features
Phase 1 Unknown
60 enrolled